(Q46315317)

21 December 2017

retracted paper

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

A randomized trial evaluating different modalities of levosimendan administration in cardiac surgery patients with myocardial dysfunction (English)

1 reference

21 December 2017

main subject

randomized experiment

1 reference

Stefan G De Hert

1

1 reference

21 December 2017

Suraphong Lorsomradee

2

1 reference

21 December 2017

Hervé vanden Eede

3

1 reference

21 December 2017

Stefanie Cromheecke

4

1 reference

21 December 2017

Philippe J Van der Linden

5

1 reference

21 December 2017

publication date

14 May 2008

1 reference

21 December 2017

Journal of Cardiothoracic and Vascular Anesthesia

published in

1 reference

21 December 2017

volume

22

1 reference

21 December 2017

issue

5

1 reference

21 December 2017

page(s)

699-705

1 reference

21 December 2017

Effects of levosimendan on myocardial ischaemia-reperfusion injury

uses

randomized experiment

0 references

cites work

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1053/J.JVCA.2008.02.019

Choice of primary anesthetic regimen can influence intensive care unit length of stay after coronary surgery with cardiopulmonary bypass

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1053/J.JVCA.2008.02.019

Levosimendan enhances cardiac performance after cardiopulmonary bypass: a prospective, randomized placebo-controlled trial.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1053/J.JVCA.2008.02.019

Cardioprotective properties of sevoflurane in patients undergoing aortic valve replacement with cardiopulmonary bypass.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1053/J.JVCA.2008.02.019

Levosimendan, a new inotropic and vasodilator agent

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1053/J.JVCA.2008.02.019

Levosimendan in off-pump coronary artery bypass: a four-times masked controlled study

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1053/J.JVCA.2008.02.019

Myocardial efficiency during calcium sensitization with levosimendan: A noninvasive study with positron emission tomography and echocardiography in healthy volunteers*

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1053/J.JVCA.2008.02.019

Hemodynamic effects of levosimendan in patients with low-output heart failure after cardiac surgery

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1053/J.JVCA.2008.02.019

Desflurane versus propofol in patients undergoing mitral valve surgery

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1053/J.JVCA.2008.02.019

Desflurane and sevoflurane in cardiac surgery: a meta-analysis of randomized clinical trials.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1053/J.JVCA.2008.02.019

Levosimendan in cardiac surgery

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1053/J.JVCA.2008.02.019

Sustained hemodynamic effects of intravenous levosimendan

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1053/J.JVCA.2008.02.019

Influence of levosimendan, pimobendan, and milrinone on the regional distribution of cardiac output in anaesthetized dogs

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1053/J.JVCA.2008.02.019

Evidence-based use of levosimendan in different clinical settings

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1053/J.JVCA.2008.02.019

European system for cardiac operative risk evaluation (EuroSCORE).

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1053/J.JVCA.2008.02.019

Levosimendan is superior to milrinone and dobutamine in selectively increasing microvascular gastric mucosal oxygenation in dogs

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1053/J.JVCA.2008.02.019

Levosimendan, a new positive inotropic drug, decreases myocardial infarct size via activation of K(ATP) channels

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1053/J.JVCA.2008.02.019

Effects of levosimendan, a novel inotropic calcium-sensitizing drug, in experimental septic shock.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1053/J.JVCA.2008.02.019

Effects of a new calcium sensitizer, levosimendan, on haemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1053/J.JVCA.2008.02.019

Efficacy and safety of perioperative infusion of levosimendan in patients with compromised cardiac function undergoing open-heart surgery: importance of early use

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1053/J.JVCA.2008.02.019

Comparison of two different loading doses of milrinone for weaning from cardiopulmonary bypass

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1053/J.JVCA.2008.02.019

Effects of OR-1896, an active metabolite of levosimendan, on contractile force and aequorin light transients in intact rabbit ventricular myocardium

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1053/J.JVCA.2008.02.019

Pharmacodynamics and safety of a new calcium sensitizer, levosimendan, and its metabolites during an extended infusion in patients with severe heart failure

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1053/J.JVCA.2008.02.019

Inotropic effects of OR-1896, an active metabolite of levosimendan, on canine ventricular myocardium

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1053/J.JVCA.2008.02.019

Myocardial efficiency during levosimendan infusion in congestive heart failure.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1053/J.JVCA.2008.02.019

Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1053/J.JVCA.2008.02.019

Levosimendan may improve survival in patients requiring mechanical assist devices for post-cardiotomy heart failure

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1053/J.JVCA.2008.02.019

Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1053/J.JVCA.2008.02.019

The cardioprotective effects of levosimendan: preclinical and clinical evidence

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1053/J.JVCA.2008.02.019

A standardized multidisciplinary approach reduces the use of allogeneic blood products in patients undergoing cardiac surgery.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1053/J.JVCA.2008.02.019

Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its administration

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1053/J.JVCA.2008.02.019

Levosimendan in cardiac surgery: current best available evidence

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1053/J.JVCA.2008.02.019

The effects of levosimendan in cardiac surgery patients with poor left ventricular function

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1053/J.JVCA.2008.02.019

Preconditioning effects of levosimendan in coronary artery bypass grafting—a pilot study

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1053/J.JVCA.2008.02.019

Levosimendan improves renal function in patients with acute decompensated heart failure: comparison with dobutamine

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1053/J.JVCA.2008.02.019

Myocardial damage prevented by volatile anesthetics: a multicenter randomized controlled study.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1053/J.JVCA.2008.02.019

Identifiers

DOI

10.1053/J.JVCA.2008.02.019

1 reference

21 December 2017

1 reference

21 December 2017